KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biogen (BIIB) Income from Continuing Operations (2016 - 2025)

Biogen (BIIB) has 17 years of Income from Continuing Operations data on record, last reported at 48900000.0 in Q4 2025.

  • For Q4 2025, Income from Continuing Operations fell 118.34% year-over-year to 48900000.0; the TTM value through Dec 2025 reached 1292900000.0, down 20.79%, while the annual FY2025 figure was 1292900000.0, 20.79% down from the prior year.
  • Income from Continuing Operations reached 48900000.0 in Q4 2025 per BIIB's latest filing, down from 466500000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 1134900000.0 in Q3 2022 and bottomed at 141200000.0 in Q3 2023.
  • Average Income from Continuing Operations over 5 years is 443680000.0, with a median of 408100000.0 recorded in 2021.
  • Peak YoY movement for Income from Continuing Operations: surged 1534.73% in 2022, then tumbled 118.34% in 2025.
  • A 5-year view of Income from Continuing Operations shows it stood at 38300000.0 in 2021, then soared by 1534.73% to 549500000.0 in 2022, then crashed by 46.93% to 291600000.0 in 2023, then fell by 8.54% to 266700000.0 in 2024, then crashed by 118.34% to 48900000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Income from Continuing Operations were 48900000.0 in Q4 2025, 466500000.0 in Q3 2025, and 634800000.0 in Q2 2025.